摘要
目的:观察后巩膜加固术(posterior scleral reinforcement surgery,PSR)后眼内屈光手术治疗病理性近视的临床疗效。方法:对178例(323眼)病理性近视患者先行后巩膜加固术,1mo后再行眼内屈光手术,随访18mo。结果:最佳矫正视力(BCVA)PSR手术前后为4.65±0.38和4.72±0.33,差异有统计学意义(P<0.05),眼内屈光手术后1,12,18mo为4.80±0.30,4.86±0.29,4.82±0.31,与屈光手术前比较差异均有统计学意义(P<0.05);屈光度眼内屈光手术前及手术后1,12,18mo分别为-16.36±5.03D和-0.98±1.23D,-0.99±1.24D,-0.96±0.99D,术后各时期分别比较差异无统计学意义(P>0.05);眼轴PSR手术前后为29.92±2.68mm和29.80±2.58mm,差异无统计学意义(P>0.05),眼内屈光手术术后18mo眼轴为29.84±2.56mm,与术前比较差异无统计学意义(P>0.05);手术无严重并发症发生。结论:对于病理性近视患者,行后巩膜加固术后的眼内屈光手术进行屈光矫正,有效稳定,远期效果尚待进一步观察。
AIM ：To observe the clinical curative effects of posterior scleral reinforcement surgery （PSR）combined with refractive lens exchange （ RLE ） or phakic intraocular lens （ PIOL ） in treating patients with pathological myopia.
METHODS： One hundred and seventy-eight pathological myopia patients （323 eyes） were treated with posterior scleral reinforcement surgery, and then were treated with RLE or PIOL 1 month later. The patients had been followed up for 18 months. RESULTS： One month to 12 months, 18 months after surgery following up showed that： best corrected visual acuity （BCVA） was seen after PSR from 4.65 ± 0.38 to 4. 72 ± 0.33（ P〈 0.05）, No statistically significant changes were seen in BCVA after refractive surgery; no statistically significant changes were seen in the eye＇s diopter between each period after the refractive surgery （P 〉 0.05）; before PSR to 1 month after PSR and 18 months after refractive surgery following up showed that there were no statistical differences （ P 〉 0. 05） between each period of the average size of ocular axis. No serious complications occurred.
CONCLUSION： Posterior scleral reinforcement surgery combined with RLE or PIOL in treating pathological myopia patients is an effective, feasible and safe operation approach. But long time follow-up is still required.
出处
《国际眼科杂志》
CAS
2008年第3期532-534,共3页
International Eye Science
关键词
病理性近视
后巩膜加固术
眼内屈光手术
pathological myopia
posterior scleral reinforcement surgery
intraocular refractive surgery
